Citations (216)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Erin Sternhagen, Brittany Bettendorf, Aleksander Lenert & Petar S Lenert. (2022) The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current Perspectives. Journal of Inflammation Research 15, pages 1133-1145.
Read now
Read now
Kit San Yeung, Tsz Leung Lee, Mo Yin Mok, Christopher Chun Yu Mak, Wanling Yang, Patrick Chun Yin Chong, Pamela Pui Wah Lee, Marco Hok Kung Ho, Sanaa Choufani, Chak Sing Lau, Yu Lung Lau, Rosanna Weksberg & Brian Hon Yin Chung. (2019) Cell lineage-specific genome-wide DNA methylation analysis of patients with paediatric-onset systemic lupus erythematosus. Epigenetics 14:4, pages 341-351.
Read now
Read now
Christopher H. Mauney & Thomas Hollis. (2018) SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity. Autoimmunity 51:3, pages 96-110.
Read now
Read now
Aleksander Lenert, Timothy B Niewold & Petar Lenert. (2017) Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Design, Development and Therapy 11, pages 747-757.
Read now
Read now
Anna Sophie Klaeschen & Joerg Wenzel. (2016) Upcoming therapeutic targets in cutaneous lupus erythematous. Expert Review of Clinical Pharmacology 9:4, pages 567-578.
Read now
Read now
Kyle A. Serikawa, Søren Jacobsen, Dorthe Lundsgaard, Brian A. Fox, Lone Hummelshoj, Lars K. Poulsen, Jan Fleckner & Klaus Stensgaard Frederiksen. (2013) Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients. Modern Rheumatology 23:4, pages 729-740.
Read now
Read now
Michael R York. (2011) Novel insights on the role of the innate immune system in systemic sclerosis. Expert Review of Clinical Immunology 7:4, pages 481-489.
Read now
Read now
Donna L Thibault Flesher, Xin Sun, Timothy W Behrens, Robert R Graham & Lindsey A Criswell. (2010) Recent advances in the genetics of systemic lupus erythematosus. Expert Review of Clinical Immunology 6:3, pages 461-479.
Read now
Read now
Henry J. Lee & Animesh A. Sinha. (2006) Cutaneous lupus erythematosus: Understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity 39:6, pages 433-444.
Read now
Read now
Articles from other publishers (207)
Martina Rossano, Emilio Amleto Conti, Paola Bocca, Stefano Volpi, Antonio Mastrangelo, Riccardo Cavalli, Marco Gattorno, Francesca Minoia & Giovanni Filocamo. (2023) Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report. Frontiers in Immunology 14.
Crossref
Crossref
Francesca Romana Spinelli, Riccardo Berti, Gabriele Farina, Fulvia Ceccarelli, Fabrizio Conti & Clara Crescioli. (2023) Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus. Autoimmunity Reviews 22:10, pages 103412.
Crossref
Crossref
Marc Xipell, Gema M. Lledó, Allyson C. Egan, Farah Tamirou, Cristina Serrano del Castillo, Jordi Rovira, José A. Gómez-Puerta, Adriana García-Herrera, Ricard Cervera, Andreas Kronbichler, David R.W. Jayne, Hans-Joachim Anders, Frédéric Houssiau, Gerard Espinosa & Luis F. Quintana. (2023) From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies. Autoimmunity Reviews 22:10, pages 103404.
Crossref
Crossref
Ahreum Kim, Sung Jae Choi, Gwan Gyu Song, Joo-Hang Kim & Jae Hyun Jung. (2023) Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus. Clinical Rheumatology 42:10, pages 2799-2809.
Crossref
Crossref
Fatemeh Moadab, Xiaoxing Wang, Rayan Najjar, Kennedy C. Ukadike, Shaohui Hu, Tyler Hulett, Anders A. Bengtsson, Christian Lood & Tomas Mustelin. (2023) Argonaute, Vault, and Ribosomal Proteins Targeted by Autoantibodies in Systemic Lupus Erythematosus. The Journal of Rheumatology 50:9, pages 1136-1144.
Crossref
Crossref
Haylee A. Cosgrove, Sebastien Gingras, Minjung Kim, Sheldon Bastacky, Jeremy S. Tilstra & Mark J. Shlomchik. (2023) B cell–intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice. JCI Insight 8:16.
Crossref
Crossref
Mary K Crow. (2023) Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Annals of the Rheumatic Diseases 82:8, pages 999-1014.
Crossref
Crossref
Dario Roccatello, Roberta Fenoglio, Ilaria Caniggia, Joelle Kamgaing, Carla Naretto, Irene Cecchi, Elena Rubini, Daniela Rossi, Emanuele De Simone, Giulio Del Vecchio, Martina Cozzi & Savino Sciascia. (2023) Daratumumab monotherapy for refractory lupus nephritis. Nature Medicine 29:8, pages 2041-2047.
Crossref
Crossref
Mariele Gatto, Roberto Depascale, Ana Luisa Stefanski, Eva Schrezenmeier & Thomas Dörner. (2023) Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology, pages 101864.
Crossref
Crossref
Gian Marco Moneta, Claudia Bracaglia, Ivan Caiello, Chiara Farroni, Denise Pires Marafon, Raffella Carlomagno, Linda Hiraki, Marina Vivarelli, Alessandra Gianviti, Simone Carbogno, Walter Ferlin, Cristina de Min, Earl Silverman, Rita Carsetti, Fabrizio De Benedetti & Emiliano Marasco. (2023)
Persistently active interferon‐γ pathway and expansion of T‐bet
+
B cells in a subset of patients with childhood‐onset systemic lupus erythematosus
. European Journal of Immunology 53:7.
Crossref
Crossref
Serena Fasano, Alessandra Milone, Giovanni Francesco Nicoletti, David A. Isenberg & Francesco Ciccia. (2023) Precision medicine in systemic lupus erythematosus. Nature Reviews Rheumatology 19:6, pages 331-342.
Crossref
Crossref
Kennedy C. Ukadike, Rayan Najjar, Kathryn Ni, Amanda Laine, Xiaoxing Wang, Alison Bays, Martin S. Taylor, John LaCava & Tomas Mustelin. (2023) Expression of L1 retrotransposons in granulocytes from patients with active systemic lupus erythematosus. Mobile DNA 14:1.
Crossref
Crossref
Moran Hausman-Kedem, Rachelle Herring, Marcela D Torres, Jonathan D. Santoro, Matsanga Leyila Kaseka, Carolina Vargas, Giulia Amico, Marta Bertamino, Deepti Nagesh, Jo Tilley, Allyson Schenk, Shay Ben-Shachar & Patricia L. Musolino. (2022) The Genetic Landscape of Ischemic Stroke in Children - Current Knowledge and Future Perspectives. Seminars in Pediatric Neurology 44, pages 100999.
Crossref
Crossref
Eirini Maria Stergioti, Theodora Manolakou, Dimitrios T. Boumpas & Aggelos Banos. (2022) Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting. Biomedicines 10:11, pages 2820.
Crossref
Crossref
Lauren S. Vaughn, Kenneth Frederick, Samuel B. Burnett, Nutan Sharma, D. Cristopher Bragg, Sarah Camargos, Francisco Cardoso & Rekha C. Patel. (2022) DYT-PRKRA Mutation P222L Enhances PACT’s Stimulatory Activity on Type I Interferon Induction. Biomolecules 12:5, pages 713.
Crossref
Crossref
Jinze Li, Ying Ma, Jackie K. Paquette, Amanda C. Richards, Matthew A. Mulvey, James F. Zachary, Cory Teuscher & Janis J. Weis. (2022) The Cdkn2a gene product p19 alternative reading frame (p19ARF) is a critical regulator of IFNβ-mediated Lyme arthritis. PLOS Pathogens 18:3, pages e1010365.
Crossref
Crossref
Marius‐Anton Ionescu. (2021) COVID‐19 skin lesions are rarely positive at RT‐PCR test: the macrophage activation with vascular impact and SARS‐CoV‐2‐induced cytokine storm. International Journal of Dermatology 61:1, pages 3-6.
Crossref
Crossref
Kennedy C. Ukadike, Kathryn Ni, Xiaoxing Wang, Martin S. Taylor, John LaCava, Lauren M. Pachman, Mary Eckert, Anne Stevens, Christian Lood & Tomas Mustelin. (2021) IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus. Arthritis Research & Therapy 23:1.
Crossref
Crossref
Erika L. Hubbard, Amrie C. Grammer & Peter E. Lipsky. (2021) Transcriptomics data: pointing the way to subclassification and personalized medicine in systemic lupus erythematosus. Current Opinion in Rheumatology 33:6, pages 579-585.
Crossref
Crossref
Frédéric De Ceuninck, Fanny Duguet, Audrey Aussy, Laurence Laigle & Philippe Moingeon. (2021) IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases. Drug Discovery Today 26:10, pages 2465-2473.
Crossref
Crossref
Stefania Gallucci, Sowmya Meka & Ana M. Gamero. (2021) Abnormalities of the type I interferon signaling pathway in lupus autoimmunity. Cytokine 146, pages 155633.
Crossref
Crossref
Audrey M. Hagiwara, Richard E. Moore, Daniel J. Wallace, Mariko Ishimori & Caroline A. Jefferies. (2021) Regulation of cGAS-STING pathway - Implications for systemic lupus erythematosus. Rheumatology and Immunology Research 2:3, pages 173-184.
Crossref
Crossref
Vineeta Shobha, Anu Mohan, AV Malini, Puneet Chopra, Preethi Karunanithi, Siva Subramani Thulasingam, Sabariya Selvam, Avisek Deyati, Ratika Srivastava, Sushma Basavanthappa, Nadine Lemos, S Margaret Sunitha, Debarati Mazumder Tagore, Amit Anand, Saumya Pant, Vivek Jayaswal, Manjunath Ramarao & Shailesh Dudhgaonkar. (2021) Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature. Lupus 30:5, pages 762-774.
Crossref
Crossref
N S Rasmussen, C T Nielsen, C H Nielsen & S Jacobsen. (2021) Microvesicles in active lupus nephritis show Toll-like receptor 9-dependent co-expression of galectin-3 binding protein and double-stranded DNA. Clinical and Experimental Immunology 204:1, pages 64-77.
Crossref
Crossref
Joseph F Merola, Wenting Wang, Carrie G Wager, Stefan Hamann, Xueli Zhang, Alice Thai, Christopher Roberts, Christina Lam, Cristina Musselli, Galina Marsh, Dania Rabah, Catherine Barbey, Nathalie Franchimont & Taylor L Reynolds. (2021) RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin. Lupus Science & Medicine 8:1, pages e000428.
Crossref
Crossref
Wenyu Xu, Yueyue Zhang, Xiaoqin Wang, Peiyu Liu, Dayu Gao, Bingjie Gu, Junyu Zhang, Chunmei Li, Qijie Ren, Leilei Yang, Hai Yuan, Minning Shen & Xingguo Chen. (2020) Clinical features and expression of type I interferon-inducible genes in systemic lupus erythematosus patients harboring rs1143679 polymorphism in China: a single-center, retrospective study. Clinical Rheumatology 40:3, pages 1093-1101.
Crossref
Crossref
Shaymaa Sadeq, Surar Al-Hashimi, Carmen M. Cusack & Andreas Werner. (2021) Endogenous Double-Stranded RNA. Non-Coding RNA 7:1, pages 15.
Crossref
Crossref
Kennedy C. Ukadike & Tomas Mustelin. (2021) Implications of Endogenous Retroelements in the Etiopathogenesis of Systemic Lupus Erythematosus. Journal of Clinical Medicine 10:4, pages 856.
Crossref
Crossref
Ji Hyun Sim, William G. Ambler, Isabel F. Sollohub, Mir J. Howlader, Thomas M. Li, Henry J. Lee & Theresa T. Lu. (2021) Immune Cell–Stromal Circuitry in Lupus Photosensitivity. The Journal of Immunology 206:2, pages 302-309.
Crossref
Crossref
Fanny Duguet, Céline Ortega-Ferreira, Benjamin Fould, Hélène Darville, Sylvie Berger, Agnès Chomel, Grégory Leclerc, Kai Kisand, Liis Haljasmägi, Adrian C. Hayday, Emiko Desvaux, Emmanuel Nony, Philippe Moingeon & Frédéric De Ceuninck. (2021) S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases. Journal of Translational Autoimmunity 4, pages 100093.
Crossref
Crossref
Fotios Koumpouras & Richard Bucala. 2021. Lahita's Systemic Lupus Erythematosus. Lahita's Systemic Lupus Erythematosus
169
180
.
Iris Jung-Won Lee & Michael P. Madaio. 2021. Lahita's Systemic Lupus Erythematosus. Lahita's Systemic Lupus Erythematosus
201
216
.
Kathryn Connelly & Alberta Hoi. 2021. Pathogenesis of Systemic Lupus Erythematosus. Pathogenesis of Systemic Lupus Erythematosus
53
65
.
Lindsey E. Fox, Marissa C. Locke & Deborah J. Lenschow. (2020) Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease. Frontiers in Immunology 11.
Crossref
Crossref
Mariana Postal, Jessica F Vivaldo, Ruth Fernandez-Ruiz, Jacqueline L Paredes, Simone Appenzeller & Timothy B Niewold. (2020) Type I interferon in the pathogenesis of systemic lupus erythematosus. Current Opinion in Immunology 67, pages 87-94.
Crossref
Crossref
Sven Hendrik Hagen, Florian Henseling, Jana Hennesen, Hélène Savel, Solenne Delahaye, Laura Richert, Susanne Maria Ziegler & Marcus Altfeld. (2020) Heterogeneous Escape from X Chromosome Inactivation Results in Sex Differences in Type I IFN Responses at the Single Human pDC Level. Cell Reports 33:10, pages 108485.
Crossref
Crossref
Tomas Mustelin & Kennedy C. Ukadike. (2020) How Retroviruses and Retrotransposons in Our Genome May Contribute to Autoimmunity in Rheumatological Conditions. Frontiers in Immunology 11.
Crossref
Crossref
Valeria Orefice, Fulvia Ceccarelli, Cristiana Barbati, Ramona Lucchetti, Giulio Olivieri, Enrica Cipriano, Francesco Natalucci, Carlo Perricone, Francesca Romana Spinelli, Cristiano Alessandri, Guido Valesini & Fabrizio Conti. (2020) Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients. Lupus 29:11, pages 1377-1384.
Crossref
Crossref
Goh Murayama, Asako Chiba, Taiga Kuga, Ayako Makiyama, Ken Yamaji, Naoto Tamura & Sachiko Miyake. (2020) Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients. Rheumatology 59:10, pages 2992-3002.
Crossref
Crossref
June Young Lee, Emaan Madany, Najwa El Kadi, Sumaarg Pandya, Kessandra Ng, Michifumi Yamashita, Caroline A. Jefferies & David R. Gibb. (2020) Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model. Frontiers in Immunology 11.
Crossref
Crossref
Daniel S Strasser, Sylvie Froidevaux, Virginie Sippel, Estelle Gerossier, Ursula Grieder, Gabin M Pierlot, Andrea Kieninger-Graefitsch, Enrico Vezzali, Anna K Stalder, Bérengère Renault, Jesper Ryge, Aaron Hart, Ulrich Mentzel, Peter M A Groenen, Marcel P Keller, Marten Trendelenburg, Marianne M Martinic & Mark J Murphy. (2020)
Preclinical to clinical translation of cenerimod, a novel S1P
1
receptor modulator, in systemic lupus erythematosus
. RMD Open 6:2, pages e001261.
Crossref
Crossref
Bethany D Harris, Srilalitha Kuruganti, Ashlesha Deshpande, Paul A Goepfert, W Winn Chatham & Mark R Walter. (2020) Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine. Lupus 29:9, pages 1095-1105.
Crossref
Crossref
Divaker Choubey & Ravichandran Panchanathan. (2020) Interferon (IFN)-inducible Absent in Melanoma 2 proteins in the negative regulation of the type I IFN response: Implications for lupus nephritis. Cytokine 132, pages 154682.
Crossref
Crossref
Elizabeth R. Morris, Sarah J. Caswell, Simone Kunzelmann, Laurence H. Arnold, Andrew G. Purkiss, Geoff Kelly & Ian A. Taylor. (2020) Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis. Nature Communications 11:1.
Crossref
Crossref
Xiguang Qi, Mingzhe Shen, Peihao Fan, Xiaojiang Guo, Tianqi Wang, Ning Feng, Manling Zhang, Robert A. Sweet, Levent Kirisci & Lirong Wang. (2020) The Performance of Gene Expression Signature-Guided Drug–Disease Association in Different Categories of Drugs and Diseases. Molecules 25:12, pages 2776.
Crossref
Crossref
Michelle D. Catalina, Katherine A. Owen, Adam C. Labonte, Amrie C. Grammer & Peter E. Lipsky. (2020) The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus. Journal of Autoimmunity 110, pages 102359.
Crossref
Crossref
Sladjana Skopelja-Gardner, Jie An, Joyce Tai, Lena Tanaka, Xizhang Sun, Payton Hermanson, Rebecca Baum, Masaoki Kawasumi, Richard Green, Michael Gale, Andrea Kalus, Victoria P. Werth & Keith B. Elkon. (2020) The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent. Scientific Reports 10:1.
Crossref
Crossref
Zhihua Qin, Serena Bonifati, Corine St. Gelais, Tai-Wei Li, Sun-Hee Kim, Jenna M. Antonucci, Bijan Mahboubi, Jacob S. Yount, Yong Xiong, Baek Kim & Li Wu. (2020) The dNTPase activity of SAMHD1 is important for its suppression of innate immune responses in differentiated monocytic cells. Journal of Biological Chemistry 295:6, pages 1575-1586.
Crossref
Crossref
Abby D. Benninghoff, Melissa A. Bates, Preeti S. Chauhan, Kathryn A. Wierenga, Kristen N. Gilley, Andrij Holian, Jack R. Harkema & James J. Pestka. (2019) Docosahexaenoic Acid Consumption Impedes Early Interferon- and Chemokine-Related Gene Expression While Suppressing Silica-Triggered Flaring of Murine Lupus. Frontiers in Immunology 10.
Crossref
Crossref
Jing Zeng, Xinyu Meng, Ping Zhou, Zhihua Yin, Qinglian Xie, Hong Zou, Nan Shen, Zhizhong Ye & Yuanjia Tang. (2019) Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice. Arthritis Research & Therapy 21:1.
Crossref
Crossref
Uma Thanarajasingam, Anoohya N. Muppirala, Mark A. Jensen, Yogita Ghodke‐Puranik, Jessica M. Dorschner, Danielle M. Vsetecka, Shreyasee Amin, Ashima Makol, Floranne Ernste, Thomas Osborn, Kevin Moder, Vaidehi Chowdhary & Timothy B. Niewold. (2019) Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus. ACR Open Rheumatology 1:8, pages 499-506.
Crossref
Crossref
Christina Adamichou, Spyros Georgakis & George Bertsias. (2019) Cytokine targets in lupus nephritis: Current and future prospects. Clinical Immunology 206, pages 42-52.
Crossref
Crossref
Cristina M. Lanata, Ishan Paranjpe, Joanne Nititham, Kimberly E. Taylor, Milena Gianfrancesco, Manish Paranjpe, Shan Andrews, Sharon A. Chung, Brooke Rhead, Lisa F. Barcellos, Laura Trupin, Patricia Katz, Maria Dall’Era, Jinoos Yazdany, Marina Sirota & Lindsey A. Criswell. (2019) A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. Nature Communications 10:1.
Crossref
Crossref
Lars Rönnblom & Dag Leonard. (2019) Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Science & Medicine 6:1, pages e000270.
Crossref
Crossref
Jacqueline K. Flynn, Wendy Dankers & Eric F. Morand. (2019) Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?. Frontiers in Immunology 10.
Crossref
Crossref
Stuart J. Perper, Susan V. Westmoreland, Jozsef Karman, Rachel Twomey, Jane Seagal, Rui Wang, Bradford L. McRae & Stephen H. Clarke. (2019) Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus. The Journal of Immunology 203:1, pages 58-75.
Crossref
Crossref
Tomas Mustelin, Christian Lood & Natalia V. Giltiay. (2019) Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus. Frontiers in Immunology 10.
Crossref
Crossref
Shin-Ichiroh Saitoh, Yoshiko Mori Saitoh, Kenji Kontani, Katsuaki Sato & Kensuke Miyake. (2019) ADP-ribosylation factor-like 8b is required for the development of mouse models of systemic lupus erythematosus. International Immunology 31:4, pages 225-237.
Crossref
Crossref
John D. Mountz, Hui-Chen Hsu & Andre Ballesteros-Tato. (2019) Dysregulation of T Follicular Helper Cells in Lupus. The Journal of Immunology 202:6, pages 1649-1658.
Crossref
Crossref
Mary K. Crow, Kyriakos A. Kirou & Timothy B. Niewold. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes
137
152
.
Kerry A Casey, Xiang Guo, Michael A Smith, Shiliang Wang, Dominic Sinibaldi, Miguel A Sanjuan, Liangwei Wang, Gabor G Illei & Wendy I White. (2018) Type I interferon receptor blockade with anifrolumab corrects innate and
adaptive immune perturbations of SLE. Lupus Science & Medicine 5:1, pages e000286.
Crossref
Crossref
Jaeseon Lee, Jennifer Lee, Seung‐Ki Kwok, SeungYe Baek, Se Gwang Jang, Seung‐Min Hong, Jae‐Woong Min, Sun Shim Choi, Juhyun Lee, Mi‐La Cho & Sung‐Hwan Park. (2018)
JAK
‐1 Inhibition Suppresses Interferon‐Induced
BAFF
Production in Human Salivary Gland
. Arthritis & Rheumatology 70:12, pages 2057-2066.
Crossref
Crossref
Casper Marsman, Fanny Lafouresse, Yang Liao, Tracey M Baldwin, Lisa A Mielke, Yifang Hu, Matthias Mack, Paul J Hertzog, Carolyn A Graaf, Wei Shi & Joanna R Groom. (2018) Plasmacytoid dendritic cell heterogeneity is defined by CXCL10 expression following TLR7 stimulation. Immunology & Cell Biology 96:10, pages 1083-1094.
Crossref
Crossref
Y. M. El-Sherbiny, A. Psarras, M. Y. Md Yusof, E. M. A. Hensor, R. Tooze, G. Doody, A. A. A Mohamed, D. McGonagle, M. Wittmann, P. Emery & E. M. Vital. (2018) A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports 8:1.
Crossref
Crossref
Partho Sen, Esko Kemppainen & Matej Orešič. (2018) Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells. Frontiers in Molecular Biosciences 4.
Crossref
Crossref
Michael H. Lee, Marita Chakhtoura, Uma Sriram, Roberto Caricchio & Stefania Gallucci. (2018) Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen. Journal of Immunology Research 2018, pages 1-21.
Crossref
Crossref
Goh Murayama, Nanako Furusawa, Asako Chiba, Ken Yamaji, Naoto Tamura & Sachiko Miyake. (2017) Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Research & Therapy 19:1.
Crossref
Crossref
David R. Gibb, Jingchun Liu, Manjula Santhanakrishnan, Prabitha Natarajan, David J. Madrid, Seema Patel, Stephanie C. Eisenbarth, Christopher A. Tormey, Sean R. Stowell, Akiko IwasakiJeanne E. Hendrickson. (2017) B cells require Type 1 interferon to produce alloantibodies to transfused KEL‐expressing red blood cells in mice. Transfusion 57:11, pages 2595-2608.
Crossref
Crossref
David R. Gibb, Jingchun Liu, Prabitha Natarajan, Manjula Santhanakrishnan, David J. Madrid, Stephanie C. Eisenbarth, James C. Zimring, Akiko Iwasaki & Jeanne E. Hendrickson. (2017) Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice. The Journal of Immunology 199:3, pages 1041-1050.
Crossref
Crossref
Lin Gao, Anna K. Bird, Nida Meednu, Kristin Dauenhauer, Jane Liesveld, Jennifer Anolik & R. John Looney. (2017) Bone Marrow–Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence‐Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein–Interferon‐β Feedback Loop. Arthritis & Rheumatology 69:8, pages 1623-1635.
Crossref
Crossref
Miaomiao Li, Dong Zhang, Mengying Zhu, Yuxian Shen, Wei Wei, Songcheng Ying, Heinrich Korner & Jun Li. (2017) Roles of SAMHD1 in antiviral defense, autoimmunity and cancer. Reviews in Medical Virology 27:4, pages e1931.
Crossref
Crossref
Aleš GoropevšekMaksimiljan GorenjakSuzana GradišnikKlara DaiIztok HolcRadovan HojsIvan KrajncArtur PahorTadej Avčin. (2017)
Increased Levels of STAT1 Protein in Blood CD4 T Cells from Systemic Lupus Erythematosus Patients Are Associated with Perturbed Homeostasis of Activated CD45RA
-
FOXP3
hi
Regulatory Subset and Follow-Up Disease Severity
. Journal of Interferon & Cytokine Research 37:6, pages 254-268.
Crossref
Crossref
Olga Zharkova, Teja Celhar, Petra D. Cravens, Anne B. Satterthwaite, Anna-Marie Fairhurst & Laurie S. Davis. (2017) Pathways leading to an immunological disease: systemic lupus erythematosus. Rheumatology 56:suppl_1, pages i55-i66.
Crossref
Crossref
Santosh K Panda, Roland Kolbeck & Miguel A Sanjuan. (2017) Plasmacytoid dendritic cells in autoimmunity. Current Opinion in Immunology 44, pages 20-25.
Crossref
Crossref
Antonios Psarras, Paul Emery & Edward M. Vital. (2017) Type I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy. Rheumatology, pages kew431.
Crossref
Crossref
Kit San Yeung, Brian Hon-Yin Chung, Sanaa Choufani, Mo Yin Mok, Wai Lap Wong, Christopher Chun Yu Mak, Wanling Yang, Pamela Pui Wah Lee, Wilfred Hing Sang Wong, Yi-an Chen, Daria Grafodatskaya, Raymond Woon Sing Wong, Chak Sing Lau, Daniel Tak Mao Chan, Rosanna Weksberg & Yu-Lung Lau. (2017) Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway. PLOS ONE 12:1, pages e0169553.
Crossref
Crossref
Michael G Kemp. (2017) Crosstalk Between Apoptosis and Autophagy: Environmental Genotoxins, Infection, and Innate Immunity. Journal of Cell Death 10, pages 117967071668508.
Crossref
Crossref
Mary K. Crow. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology
1329
1344
.
Thuy L. Phung, Teresa S. Wright, Crystal Y. Pourciau & Bruce R. SmollerThuy L. Phung, Teresa S. Wright, Crystal Y. Pourciau & Bruce R. Smoller. 2017. Pediatric Dermatopathology. Pediatric Dermatopathology
87
120
.
Sambit K. Nanda, Marta Lopez-Pelaez, J. Simon C. Arthur, Francesco Marchesi & Philip Cohen. (2016) Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding–Defective Mutant of ABIN1. The Journal of Immunology 197:11, pages 4266-4273.
Crossref
Crossref
Mikhail Olferiev, Elzbieta Jacek, Kyriakos A. Kirou & Mary K. Crow. (2016) Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus. Clinical Immunology 172, pages 34-43.
Crossref
Crossref
Peter D. Burbelo, Michael J. Iadarola, Ilias Alevizos & Matthew R. Sapio. (2016) Transcriptomic Segregation of Human Autoantigens Useful for the Diagnosis of Autoimmune Diseases. Molecular Diagnosis & Therapy 20:5, pages 415-427.
Crossref
Crossref
Matthew A. Care, Sophie J. Stephenson, Nicholas A. Barnes, Im Fan, Alexandre Zougman, Yasser M. El-Sherbiny, Edward M. Vital, David R. Westhead, Reuben M. Tooze & Gina M. Doody. (2016) Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity. The Journal of Immunology 197:4, pages 1447-1459.
Crossref
Crossref
A Kuhn, A Landmann & J Wenzel. (2016) Advances in the treatment of cutaneous lupus erythematosus. Lupus 25:8, pages 830-837.
Crossref
Crossref
Colin Thorbinson, Louise Oni, Eve Smith, Angela Midgley & Michael W. Beresford. (2016) Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus. Pediatric Drugs 18:3, pages 181-195.
Crossref
Crossref
Namrata Singh, Bharat Kumar, Vijay Aluri & Petar Lenert. (2016) Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations. Journal of Allergy and Clinical Immunology 137:5, pages 1325-1333.
Crossref
Crossref
Shweta Jain, Giljun Park, Thomas J. Sproule, Gregory J. Christianson, Caroline M. Leeth, Hongsheng Wang, Derry C. Roopenian & Herbert C. Morse. (2016) Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa Mice. PLOS ONE 11:4, pages e0153059.
Crossref
Crossref
Consuelo M. López de Padilla & Timothy B. Niewold. (2016) The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases. Gene 576:1, pages 14-21.
Crossref
Crossref
Richard Furie, Kiley Toder & Ekaterini Zapantis. (2015) Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis. Seminars in Nephrology 35:5, pages 509-520.
Crossref
Crossref
Paul M. Gallo, Glenn J. Rapsinski, R. Paul Wilson, Gertrude O. Oppong, Uma Sriram, Mark Goulian, Bettina Buttaro, Roberto Caricchio, Stefania Gallucci & Çagla Tükel. (2015) Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity. Immunity 42:6, pages 1171-1184.
Crossref
Crossref
Corinne Miceli-Richard. (2015) Epigenetics and lupus. Joint Bone Spine 82:2, pages 90-93.
Crossref
Crossref
Mary K. Crow, Mikhail Olferiev & Kyriakos A. Kirou. (2015) Targeting of type I interferon in systemic autoimmune diseases. Translational Research 165:2, pages 296-305.
Crossref
Crossref
Christopher Chang. 2015. Personalized Epigenetics. Personalized Epigenetics
475
505
.
Ying Ma, Kenneth K. C. Bramwell, Robert B. Lochhead, Jackie K. Paquette, James F. Zachary, John H. Weis, Cory Teuscher & Janis J. Weis. (2014)
Borrelia burgdorferi
Arthritis–Associated Locus
Bbaa1
Regulates Lyme Arthritis and K/B×N Serum Transfer Arthritis through Intrinsic Control of Type I IFN Production
. The Journal of Immunology 193:12, pages 6050-6060.
Crossref
Crossref
Mileka Gilbert & Marilynn Punaro. (2014) Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside. Pediatric Rheumatology 12:1.
Crossref
Crossref
Corinne Miceli-Richard. (2014) Épigénétique et lupus. Revue du Rhumatisme 81:5, pages 381-384.
Crossref
Crossref
Sarah L. Rowland, Jeffrey M. Riggs, Susan Gilfillan, Mattia Bugatti, William Vermi, Roland Kolbeck, Emil R. Unanue, Miguel A. Sanjuan & Marco Colonna. (2014) Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. Journal of Experimental Medicine 211:10, pages 1977-1991.
Crossref
Crossref
Mary K. Crow. (2014) Advances in understanding the role of type I interferons in systemic lupus erythematosus. Current Opinion in Rheumatology 26:5, pages 467-474.
Crossref
Crossref
Yinxia Chao, Nivashini Kaliaperumal, Anne-Sophie Chretien, Suisheng Tang, Bernett Lee, Michael Poidinger, Anna-Marie Fairhurst & John E Connolly. (2014) Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. Journal of Leukocyte Biology 96:6, pages 1037-1046.
Crossref
Crossref
R. Dey-Rao, J.R. Smith, S. Chow & A.A. Sinha. (2014) Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease. Genomics 104:2, pages 144-155.
Crossref
Crossref
Mary K. Crow. (2014) Type I Interferon in the Pathogenesis of Lupus. The Journal of Immunology 192:12, pages 5459-5468.
Crossref
Crossref
Peter K. Gregersen & Michaela Oswald. (2014) Editorial: The Power of a Modular Approach to Transcriptional Analysis. Arthritis & Rheumatology 66:6, pages 1418-1420.
Crossref
Crossref
Laurent Chiche, Noémie Jourde-Chiche, Elizabeth Whalen, Scott Presnell, Vivian Gersuk, Kristen Dang, Esperanza Anguiano, Charlie Quinn, Stéphane Burtey, Yvon Berland, Gilles Kaplanski, Jean-Robert Harle, Virginia Pascual & Damien Chaussabel. (2014) Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures. Arthritis & Rheumatology 66:6, pages 1583-1595.
Crossref
Crossref
Jun Xu, Philip W Zoltick, Ana M Gamero & Stefania Gallucci. (2014) TLR ligands up-regulate Trex1 expression in murine conventional dendritic cells through type I Interferon and NF-κB-dependent signaling pathways. Journal of Leukocyte Biology 96:1, pages 93-103.
Crossref
Crossref
YUNPENG SHI, GUOYUE LV, ZHE CHU, LILING PIAO, XINGKAI LIU, TUO WANG, YANFANG JIANG & PING ZHANG. (2014) Identification of natural splice variants of SAMHD1 in virus-infected HCC. Oncology Reports 31:2, pages 687-692.
Crossref
Crossref
Paul R. Dominguez-Gutierrez, Angela Ceribelli, Minoru Satoh, Eric S. Sobel, Westley H. Reeves & Edward K. L. Chan. (2013) Positive Correlation of STAT1 and miR-146a with Anemia in Patients with Systemic Lupus Erythematosus. Journal of Clinical Immunology 34:2, pages 171-180.
Crossref
Crossref
Paul R Dominguez-Gutierrez, Angela Ceribelli, Minoru Satoh, Eric S Sobel, Westley H Reeves & Edward KL Chan. (2014) Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset. Arthritis Research & Therapy 16:1, pages R23.
Crossref
Crossref
Jin-Hwan Han, Benjamin R. Umiker, Anastasia A. Kazimirova, Michael Fray, Parimal Korgaonkar, Erik Selsing & Thereza Imanishi-Kari. (2014) Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression. European Journal of Immunology 44:1, pages 215-226.
Crossref
Crossref
Kyriakos A. Kirou & Elena Gkrouzman. (2013) Anti-interferon alpha treatment in SLE. Clinical Immunology 148:3, pages 303-312.
Crossref
Crossref
Paola Mina-Osorio, Jacob LaStant, Natalie Keirstead, Toni Whittard, Julia Ayala, Stella Stefanova, Rosario Garrido, Nena Dimaano, Holly Hilton, Mario Giron, Kai-Yeung Lau, Julie Hang, Jennifer Postelnek, Yong Kim, Soo Min, Alka Patel, John Woods, Meera Ramanujam, Julie DeMartino, Satwant Narula & Daigen Xu. (2013) Suppression of Glomerulonephritis in Lupus-Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase. Arthritis & Rheumatism 65:9, pages 2380-2391.
Crossref
Crossref
Bo Zhang, Justin A. Jarrell, Jordan V. Price, Scott M. Tabakman, Yanguang Li, Ming Gong, Guosong Hong, Ju Feng, Paul J. Utz & Hongjie Dai. (2013) An Integrated Peptide-Antigen Microarray on Plasmonic Gold Films for Sensitive Human Antibody Profiling. PLoS ONE 8:7, pages e71043.
Crossref
Crossref
Mary K. Crow, Timothy B. Niewold & Kyriakos A. Kirou. 2013. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes
62
75
.
Mary K. Crow. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology
1269
1282
.
H Levy, X Wang, M Kaldunski, S Jia, J Kramer, S J Pavletich, M Reske, T Gessel, M Yassai, M W Quasney, M K Dahmer, J Gorski & M J Hessner. (2012) Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes. Genes & Immunity 13:8, pages 593-604.
Crossref
Crossref
Paola G Bronson, Christina Chaivorapol, Ward Ortmann, Timothy W Behrens & Robert R Graham. (2012) The genetics of type I interferon in systemic lupus erythematosus. Current Opinion in Immunology 24:5, pages 530-537.
Crossref
Crossref
Rachael A. Gordon, Galina Grigoriev, Angela Lee, George D. Kalliolias & Lionel B. Ivashkiv. (2012)
The interferon signature and
STAT1
expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter‐regulated by the synovial fluid microenvironment
. Arthritis & Rheumatism 64:10, pages 3119-3128.
Crossref
Crossref
Christian Lood, Maria Allhorn, Rolf Lood, Birgitta Gullstrand, Anders I. Olin, Lars Rönnblom, Lennart Truedsson, Mattias Collin & Anders A. Bengtsson. (2012) IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?. Arthritis & Rheumatism 64:8, pages 2698-2706.
Crossref
Crossref
Uma Sriram, Linda Varghese, Heather L. Bennett, Neelakshi R. Jog, Debra K. Shivers, Yue Ning, Edward M. Behrens, Roberto Caricchio & Stefania Gallucci. (2012) Myeloid Dendritic Cells from B6.NZM Sle1/Sle2/Sle3 Lupus-Prone Mice Express an IFN Signature That Precedes Disease Onset. The Journal of Immunology 189:1, pages 80-91.
Crossref
Crossref
Holden T. Maecker, Tamsin M. Lindstrom, William H. Robinson, Paul J. Utz, Matthew Hale, Scott D. Boyd, Shai S. Shen-Orr & C. Garrison Fathman. (2012) New tools for classification and monitoring of autoimmune diseases. Nature Reviews Rheumatology 8:6, pages 317-328.
Crossref
Crossref
Douglas R. McDonald. (2012) TH17 deficiency in human disease. Journal of Allergy and Clinical Immunology 129:6, pages 1429-1435.
Crossref
Crossref
Theresa L. Geurs, Elaise B. Hill, Danna M. Lippold & Anthony R. French. (2012) Sex differences in murine susceptibility to systemic viral infections. Journal of Autoimmunity 38:2-3, pages J245-J253.
Crossref
Crossref
Anders A. Bengtsson, Gunnar Sturfelt, Christian Lood, Lars Rönnblom, Ronald F. van Vollenhoven, Bengt Axelsson, Birgitta Sparre, Helén Tuvesson, Marie Wallén Öhman & Tomas Leanderson. (2012) Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR‐215757), a new quinoline‐3‐carboxamide derivative: Studies in lupus‐prone mice and a multicenter, randomized, double‐blind, placebo‐controlled, repeat‐dose, dose‐ranging study in patients with systemic lupus erythematosus. Arthritis & Rheumatism 64:5, pages 1579-1588.
Crossref
Crossref
Alberto de Zubiria Salgado & Catalina Herrera-Diaz. (2012) Lupus Nephritis: An Overview of Recent Findings. Autoimmune Diseases 2012, pages 1-21.
Crossref
Crossref
Christopher Chang. 2012. Epigenetics in Human Disease. Epigenetics in Human Disease
225
251
.
Isabelle T.M.N. DaissormontAnette ChristLieve TemmermanStefan Sampedro MillaresTom SeijkensMarco MancaMat RouschMarjorie PoggiLouis BoonChris van der LoosMat DaemenEsther LutgensBente HalvorsenPal AukrustEdith JanssenErik A.L. Biessen. (2011) Plasmacytoid Dendritic Cells Protect Against Atherosclerosis by Tuning T-Cell Proliferation and Activity. Circulation Research 109:12, pages 1387-1395.
Crossref
Crossref
Timothy B. Niewold. (2011) Interferon Alpha as a Primary Pathogenic Factor in Human Lupus. Journal of Interferon & Cytokine Research 31:12, pages 887-892.
Crossref
Crossref
Rebecca D. Powell, Paul J. Holland, Thomas Hollis & Fred W. Perrino. (2011) Aicardi-Goutières Syndrome Gene and HIV-1 Restriction Factor SAMHD1 Is a dGTP-regulated Deoxynucleotide Triphosphohydrolase. Journal of Biological Chemistry 286:51, pages 43596-43600.
Crossref
Crossref
Laurie S. DavisJack HutchesonChandra Mohan. (2011) The Role of Cytokines in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Journal of Interferon & Cytokine Research 31:10, pages 781-789.
Crossref
Crossref
Yaming Wang, Melissa Swiecki, Stephen A. McCartney & Marco Colonna. (2011) dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunological Reviews 243:1, pages 74-90.
Crossref
Crossref
Jessica S. KimVictoria P. Werth. (2011) Identification of Specific Chondroitin Sulfate Species in Cutaneous Autoimmune Disease. Journal of Histochemistry & Cytochemistry 59:8, pages 780-790.
Crossref
Crossref
Maria Dall’Era & Eliza F. Chakravarty. (2011) Treatment of Mild, Moderate, and Severe Lupus Erythematosus: Focus on New Therapies. Current Rheumatology Reports 13:4, pages 308-316.
Crossref
Crossref
Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse & Hans Carl Hasselbalch. (2011) Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis. European Journal of Haematology 87:1, pages 54-60.
Crossref
Crossref
Naoya MIKITA, Takaharu IKEDA, Mariko ISHIGURO & Fukumi FURUKAWA. (2011) Recent advances in cytokines in cutaneous and systemic lupus erythematosus. The Journal of Dermatology, pages no-no.
Crossref
Crossref
Rafah Salloum & Timothy B. Niewold. (2011) Interferon regulatory factors in human lupus pathogenesis. Translational Research 157:6, pages 326-331.
Crossref
Crossref
Nagako Akeno, Eric P. Smith, Mihaela Stefan, Amanda K. Huber, Weijia Zhang, Mehdi Keddache & Yaron Tomer. (2011) IFN-α Mediates the Development of Autoimmunity both by Direct Tissue Toxicity and through Immune Cell Recruitment Mechanisms. The Journal of Immunology 186:8, pages 4693-4706.
Crossref
Crossref
Corinna E. Weckerle, Beverly S. Franek, Jennifer A. Kelly, Marissa Kumabe, Rachel A. Mikolaitis, Stephanie L. Green, Tammy O. Utset, Meenakshi Jolly, Judith A. James, John B. Harley & Timothy B. Niewold. (2011) Network analysis of associations between serum interferon‐α activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis & Rheumatism 63:4, pages 1044-1053.
Crossref
Crossref
Julien Pothlichet, Timothy B. Niewold, Damien Vitour, Brigitte Solhonne, Mary K. Crow & Mustapha Si‐Tahar. (2011) A loss‐of‐function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Molecular Medicine 3:3, pages 142-152.
Crossref
Crossref
Christian Lood, Martin Stenström, Helena Tydén, Birgitta Gullstrand, Eva Källberg, Tomas Leanderson, Lennart Truedsson, Gunnar Sturfelt, Fredrik Ivars & Anders A Bengtsson. (2011) Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus. Arthritis Research & Therapy 13:2, pages R60.
Crossref
Crossref
Mary K. Crow. 2011. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
307
320
.
Giuseppina A. Farina, Michael R. York, Michael Di Marzio, Cindy A. Collins, Stephan Meller, Bernhard Homey, Ian R. Rifkin, Ann Marshak-Rothstein, Timothy R.D.J. Radstake & Robert Lafyatis. (2010) Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis. Journal of Investigative Dermatology 130:11, pages 2583-2593.
Crossref
Crossref
Adriana Albini, Stefano Indraccolo, Douglas M. Noonan & Ulrich Pfeffer. (2010) Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs. Clinical & Experimental Metastasis 27:6, pages 419-439.
Crossref
Crossref
Melissa Swiecki & Marco Colonna. (2010) Accumulation of plasmacytoid DC: Roles in disease pathogenesis and targets for immunotherapy. European Journal of Immunology 40:8, pages 2094-2098.
Crossref
Crossref
Melissa Swiecki & Marco Colonna. (2010) Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunological Reviews 234:1, pages 142-162.
Crossref
Crossref
Silvia N. Kariuki & Timothy B. Niewold. (2010) Genetic regulation of serum cytokines in systemic lupus erythematosus. Translational Research 155:3, pages 109-117.
Crossref
Crossref
Mary K. Crow. (2010) Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 36:1, pages 173-186.
Crossref
Crossref
George D Kalliolias & Lionel B Ivashkiv. (2010) Overview of the biology of type I interferons. Arthritis Research & Therapy 12:Suppl 1, pages S1.
Crossref
Crossref
Danny Zipris. 2010. The Islets of Langerhans. The Islets of Langerhans
585
610
.
Michael F SmithJrJr, Falk Hiepe, Thomas Dörner & Gerd Burmester. (2009) Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis. Arthritis Research & Therapy 11:6.
Crossref
Crossref
Emily Walters, Virginia Rider, Nabih I. Abdou, Cindy Greenwell, Stan Svojanovsky, Peter Smith & Bruce F. Kimler. (2009) Estradiol targets T cell signaling pathways in human systemic lupus. Clinical Immunology 133:3, pages 428-436.
Crossref
Crossref
Anna-Marie Fairhurst, Chun Xie, Yuyang Fu, Andrew Wang, Christopher Boudreaux, Xin J. Zhou, Ricardo Cibotti, Anthony Coyle, John E. Connolly, Edward K. Wakeland & Chandra Mohan. (2009) Type I Interferons Produced by Resident Renal Cells May Promote End-Organ Disease in Autoantibody-Mediated Glomerulonephritis. The Journal of Immunology 183:10, pages 6831-6838.
Crossref
Crossref
Christian Lood, Birgitta Gullstrand, Lennart Truedsson, Anders I. Olin, Gunnar V. Alm, Lars Rönnblom, Gunnar Sturfelt, Maija-Leena Eloranta & Anders A. Bengtsson. (2009) C1q inhibits immune complex-induced interferon-α production in plasmacytoid dendritic cells: A novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis & Rheumatism 60:10, pages 3081-3090.
Crossref
Crossref
Na Luo, Yi Wu, Yongwen Chen, Zhao Yang, Sheng Guo, Lei Fei, Di Zhou, Chengying Yang, Shengxi Wu, Bing Ni, Fei Hao & Yuzhang Wu. (2009) Upregulated BclGL expression enhances apoptosis of peripheral blood CD4+ T lymphocytes in patients with systemic lupus erythematosus. Clinical Immunology 132:3, pages 349-361.
Crossref
Crossref
Jessica K. Gordon, Cynthia Magro, Theresa Lu, Robert Schneider, April Chiu, Richard R. Furman, Garron Solomon, Anne Bass & Doruk Erkan. (2009) Overlap between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease. HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery 5:2, pages 169-177.
Crossref
Crossref
Elsa Sousa & David Isenberg. (2009) Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies. Best Practice & Research Clinical Rheumatology 23:4, pages 563-574.
Crossref
Crossref
Gillian I Rice, Jacquelyn Bond, Aruna Asipu, Rebecca L Brunette, Iain W Manfield, Ian M Carr, Jonathan C Fuller, Richard M Jackson, Teresa Lamb, Tracy A Briggs, Manir Ali, Hannah Gornall, Lydia R Couthard, Alec Aeby, Simon P Attard-Montalto, Enrico Bertini, Christine Bodemer, Knut Brockmann, Louise A Brueton, Peter C Corry, Isabelle Desguerre, Elisa Fazzi, Angels Garcia Cazorla, Blanca Gener, Ben C J Hamel, Arvid Heiberg, Matthew Hunter, Marjo S van der Knaap, Ram Kumar, Lieven Lagae, Pierre G Landrieu, Charles M Lourenco, Daphna Marom, Michael F McDermott, William van der Merwe, Simona Orcesi, Julie S Prendiville, Magnhild Rasmussen, Stavit A Shalev, Doriette M Soler, Marwan Shinawi, Ronen Spiegel, Tiong Y Tan, Adeline Vanderver, Emma L Wakeling, Evangeline Wassmer, Elizabeth Whittaker, Pierre Lebon, Daniel B Stetson, David T Bonthron & Yanick J Crow. (2009) Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nature Genetics 41:7, pages 829-832.
Crossref
Crossref
Elaine V. Lourenço, Claudio Procaccini, Francesca Ferrera, Noriko Iikuni, Ram P. Singh, Gilberto Filaci, Giuseppe Matarese, Fu-Dong Shi, Ernest Brahn, Bevra H. Hahn & Antonio La Cava. (2009) Modulation of p38 MAPK Activity in Regulatory T Cells after Tolerance with Anti-DNA Ig Peptide in (NZB × NZW)F1 Lupus Mice. The Journal of Immunology 182:12, pages 7415-7421.
Crossref
Crossref
Bahram Namjou, Andrea L. Sestak, Don L. Armstrong, Raphael Zidovetzki, Jennifer A. Kelly, Noam Jacob, Voicu Ciobanu, Kenneth M. Kaufman, Joshua O. Ojwang, Julie Ziegler, Francesco P. QuismorioJr.Jr., Andreas Reiff, Barry L. Myones, Joel M. Guthridge, Swapan K. Nath, Gail R. Bruner, Ruth Mehrian-Shai, Earl Silverman, Marisa Klein-Gitelman, Deborah McCurdy, Linda Wagner-Weiner, James J. Nocton, Chaim Putterman, Sang-Cheol Bae, Yun Jung Kim, Michelle Petri, John D. Reveille, Timothy J. Vyse, Gary S. Gilkeson, Diane L. Kamen, Marta E. Alarcón-Riquelme, Patrick M. Gaffney, Kathy L. Moser, Joan T. Merrill, R. Hal Scofield, Judith A. James, Carl D. Langefeld, John B. Harley & Chaim O. Jacob. (2009) High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis & Rheumatism 60:4, pages 1085-1095.
Crossref
Crossref
Yihong Yao, Brandon W. Higgs, Chris Morehouse, Melissa de los Reyes, Wendy Trigona, Philip Brohawn, Wendy White, Jianliang Zhang, Barbara White, Anthony J. Coyle, Peter A. Kiener & Bahija Jallal. (2009) Development of Potential Pharmacodynamic and Diagnostic Markers for
Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus
Erythematosus. Human Genomics and Proteomics 1:1.
Crossref
Crossref
Manfred Kunz & Saleh M. Ibrahim. (2009) Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity. Mediators of Inflammation 2009, pages 1-20.
Crossref
Crossref
Patrick G. Holt, Deborah H. Strickland, Anthony Bosco & Frode L. Jahnsen. 2009.
51
113
.
Jennifer C. Miller, Ying Ma, Jiantao Bian, Kathleen C. F. Sheehan, James F. Zachary, John H. Weis, Robert D. Schreiber & Janis J. Weis. (2008)
A Critical Role for Type I IFN in Arthritis Development following
Borrelia burgdorferi
Infection of Mice
. The Journal of Immunology 181:12, pages 8492-8503.
Crossref
Crossref
Arlene T. Tieng & Elena Peeva. (2008) B-Cell-Directed Therapies in Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism 38:3, pages 218-227.
Crossref
Crossref
J Tang, Y Gu, M Zhang, S Ye, X Chen, Q Guo, J Qian, C Bao, S Chen & N Shen. (2008) Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients. Lupus 17:9, pages 805-813.
Crossref
Crossref
Bahram Razani, Arash Shahangian, Beichu Guo & Genhong Cheng. 2008. Cellular Signaling and Innate Immune Responses to RNA Virus Infections. Cellular Signaling and Innate Immune Responses to RNA Virus Infections
155
175
.
Mary K Crow. (2008) Fast forward for systemic lupus erythematosus clinical trials. Nature Clinical Practice Rheumatology 4:8, pages 387-387.
Crossref
Crossref
Jennifer C. Miller, Ying Ma, Hillary Crandall, Xiaohui Wang & Janis J. Weis. (2008) Gene expression profiling provides insights into the pathways involved in inflammatory arthritis development: Murine model of Lyme disease. Experimental and Molecular Pathology 85:1, pages 20-27.
Crossref
Crossref
Bo Chen, Qin Zong, Ricardo Cibotti, Chad Morris, Juana Castaneda, Brian Naiman, Derong Liu, Anna Glodek, Gary P. Sims, Ronald Herbst, Stephen K. Horrigan, Peter A. Kiener, Dan Soppet, Anthony J. Coyle & Laurent Audoly. (2008) Genomic-Based High Throughput Screening Identifies Small Molecules That Differentially Inhibit the Antiviral and Immunomodulatory Effects of IFN-α. Molecular Medicine 14:7-8, pages 374-382.
Crossref
Crossref
Tomoko Okamoto, Masafumi Ogawa, Youwei Lin, Miho Murata, Sachiko Miyake & Takashi Yamamura. (2008) Review: Treatment of neuromyelitis optica: Current debate. Therapeutic Advances in Neurological Disorders 1:1, pages 43-52.
Crossref
Crossref
Damien Chaussabel, Charles Quinn, Jing Shen, Pinakeen Patel, Casey Glaser, Nicole Baldwin, Dorothee Stichweh, Derek Blankenship, Lei Li, Indira Munagala, Lynda Bennett, Florence Allantaz, Asuncion Mejias, Monica Ardura, Ellen Kaizer, Laurence Monnet, Windy Allman, Henry Randall, Diane Johnson, Aimee Lanier, Marilynn Punaro, Knut M. Wittkowski, Perrin White, Joseph Fay, Goran Klintmalm, Octavio Ramilo, A. Karolina Palucka, Jacques Banchereau & Virginia Pascual. (2008) A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus. Immunity 29:1, pages 150-164.
Crossref
Crossref
Seetha U Monrad, Karl C Desch & Mariana J Kaplan. (2008) Role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Future Rheumatology 3:3, pages 269-279.
Crossref
Crossref
Virginia Pascual, Florence Allantaz, Pinakeen Patel, A. Karolina Palucka, Damien Chaussabel & Jacques Banchereau. (2008) How the study of children with rheumatic diseases identified interferon‐α and interleukin‐1 as novel therapeutic targets. Immunological Reviews 223:1, pages 39-59.
Crossref
Crossref
Asifa S. Haider, Michelle A. Lowes, Mayte Suàrez-Fariñas, Lisa C. Zaba, Irma Cardinale, Miroslav Blumenberg & James G. Krueger. (2008) Cellular Genomic Maps Help Dissect Pathology in Human Skin Disease. Journal of Investigative Dermatology 128:3, pages 606-615.
Crossref
Crossref
Manfred Kunz. (2008) DNA Microarray Technology in Dermatology. Seminars in Cutaneous Medicine and Surgery 27:1, pages 16-24.
Crossref
Crossref
Iris J Lee & Michael P Madaio. (2008) Search for useful tools: biomarkers in lupus nephritis. Future Rheumatology 3:1, pages 1-6.
Crossref
Crossref
Nan-Hua Chang, Tamara McKenzie, Gabriel Bonventi, Carolina Landolt-Marticorena, Paul R. Fortin, Dafna Gladman, Murray Urowitz & Joan E. Wither. (2008) Expanded Population of Activated Antigen-Engaged Cells within the Naive B Cell Compartment of Patients with Systemic Lupus Erythematosus. The Journal of Immunology 180:2, pages 1276-1284.
Crossref
Crossref
Xiangyang Huang, Nanping Yang, Xuemei Ou, Dong Li, Zhongming Wang, Qibing Xie, Yongtao Chen, Hui Lin, Gen Yin & Fuqiang Wen. (2008) Sequential activation of protein kinase C δ and JNK is required for interferon-α-induced expression of IFIT4. Cellular Signalling 20:1, pages 112-119.
Crossref
Crossref
Florence Allantaz, Damien Chaussabel, Jacques Banchereau & Virginia Pascual. (2007) Microarray-based identification of novel biomarkers in IL-1-mediated diseases. Current Opinion in Immunology 19:6, pages 623-632.
Crossref
Crossref
D.A. Alcorta, D.A. Barnes, M.A. Dooley, P. Sullivan, B. Jonas, Y. Liu, S. Lionaki, C.B. Reddy, H. Chin, A.A. Dempsey, J.C. Jennette & R.J. Falk. (2007) Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney International 72:7, pages 853-864.
Crossref
Crossref
Q Lu, N Shen, X M Li & S L Chen. (2007) Genomic view of IFN-α response in pre-autoimmune NZB/W and MRL/lpr mice. Genes & Immunity 8:7, pages 590-603.
Crossref
Crossref
Doreen Finke, Katharina Randers, Robert Hoerster, Holger Hennig, Rainer Zawatzky, Tony Marion, Christian Brockmann, Katja Klempt-Giessing, Kirsten Jacobsen, Holger Kirchner & Siegfried Goerg. (2007) Elevated levels of endogenous apoptotic DNA and IFN-α in complement C4-deficient mice: Implications for induction of systemic lupus erythematosus. European Journal of Immunology 37:6, pages 1702-1709.
Crossref
Crossref
Sallyanne C. Fossey, Cindy L. Vnencak-Jones, Nancy J. Olsen, Subramaniam Sriram, Gladys Garrison, Xenquing Deng, Philip S. CrookeIIIIII & Thomas M. Aune. (2007) Identification of Molecular Biomarkers for Multiple Sclerosis. The Journal of Molecular Diagnostics 9:2, pages 197-204.
Crossref
Crossref
Seetha Monrad & Mariana J. Kaplan. (2007) Dendritic cells and the immunopathogenesis of systemic lupus erythematosus. Immunologic Research 37:2, pages 135-145.
Crossref
Crossref
Michael R. York, Taro Nagai, Alyson J. Mangini, Raphaël Lemaire, Jean Maguire van Seventer & Robert Lafyatis. (2007) A macrophage marker, siglec‐1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type i interferons and toll‐like receptor agonists. Arthritis & Rheumatism 56:3, pages 1010-1020.
Crossref
Crossref
Emily C. Baechler, Jason W. Bauer, Catherine A. Slattery, Ward A. Ortmann, Karl J. Espe, Jill Novitzke, Steven R. Ytterberg, Peter K. Gregersen, Timothy W. Behrens & Ann M. Reed. (2007) An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease Activity. Molecular Medicine 13:1-2, pages 59-68.
Crossref
Crossref
Czeslawa Kowal, Cynthia Aranow, Meggan Mackay, Betty Diamond & Bruce T. Volpe. 2007. Neurobiology of Disease. Neurobiology of Disease
171
184
.
Virginia Pascual, Lorant Farkas & Jacques Banchereau. (2006) Systemic lupus erythematosus: all roads lead to type I interferons. Current Opinion in Immunology 18:6, pages 676-682.
Crossref
Crossref
Marta E. Alarcón-Riquelme. (2006) The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility. Springer Seminars in Immunopathology 28:2, pages 109-117.
Crossref
Crossref
A K Stoeckman, E C Baechler, W A Ortmann, T W Behrens, C J Michet & E J Peterson. (2006) A distinct inflammatory gene expression profile in patients with psoriatic arthritis. Genes & Immunity 7:7, pages 583-591.
Crossref
Crossref
Kevin A. O'Connor, Kathy A. Abbott, Brad Sabin, Maxine Kuroda & Lauren M. Pachman. (2006) MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: Association with muscle involvement. Clinical Immunology 120:3, pages 319-325.
Crossref
Crossref
Beate Berghöfer, Ture Frommer, Gabriela Haley, Ludger Fink, Gregor Bein & Holger Hackstein. (2006) TLR7 Ligands Induce Higher IFN-α Production in Females. The Journal of Immunology 177:4, pages 2088-2096.
Crossref
Crossref
Mitsuteru Akahoshi, Hitoshi Nakashima & Taro Shirakawa. (2006) Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus. Seminars in Immunology 18:4, pages 224-229.
Crossref
Crossref
Displaying 200 of 216 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list